1
|
Heser K, Kleineidam L, Wagner M, Luppa M, Löbner M, Wiese B, Oey A, König HH, Brettschneider C, van der Leeden C, van den Bussche H, Fuchs A, Pentzek M, Weyerer S, Werle J, Bickel H, Scherer M, Maier W, Ramirez A, Riedel-Heller SG. Family History of Dementia in Old-Age Participants with Subjective Memory Complaints Predicts Own Risk for Dementia in a Longitudinal Multi-Center Cohort Study. J Alzheimers Dis 2023; 96:579-589. [PMID: 37840488 DOI: 10.3233/jad-230410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2023]
Abstract
BACKGROUND Subjective memory complaints and family history of dementia are possibly intertwined risk factors for the own subsequent dementia risk and Alzheimer's disease. However, their interaction has rarely been studied. OBJECTIVE To study the association between subjective memory complaints and family history of dementia with regard to the own subsequent risk of dementia. METHODS Cross-sectional and longitudinal analyses over a follow-up period of up to 13 years were conducted in a population sample of participants without dementia at baseline (n = 3,256, mean age = 79.62 years), using group comparisons and Cox proportional hazards models. RESULTS Cross-sectionally, participants with subjective memory complaints were significantly more likely to report family history of dementia. Longitudinally, family history of dementia (FH) was significantly associated with subsequent dementia in the subjective memory complaints (SMC) group, but not in those without SMC. A relative excess risk due to interaction analysis confirmed a significant FHxSMC-interaction. CONCLUSIONS Family history of dementia was a predictor of incident dementia in those with SMC, which can serve as an additional, clinically relevant criterion to gauge the risk of dementia in older-aged subjects with SMC with and without objective cognitive impairment.
Collapse
Affiliation(s)
- Kathrin Heser
- Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, North Rhine-Westphalia, Germany
| | - Luca Kleineidam
- Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, North Rhine-Westphalia, Germany
- German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany
| | - Michael Wagner
- Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, North Rhine-Westphalia, Germany
- German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany
| | - Melanie Luppa
- Institute of Social Medicine, Occupational Health and Public Health, Medical Faculty, University of Leipzig, Leipzig, Saxony, Germany
| | - Margrit Löbner
- Institute of Social Medicine, Occupational Health and Public Health, Medical Faculty, University of Leipzig, Leipzig, Saxony, Germany
| | - Birgitt Wiese
- Institute of General Practice, Working Group Medical Statistics and IT Infrastructure, Hannover Medical School, Hannover, Lower Saxony, Germany
| | - Anke Oey
- Institute of General Practice, Working Group Medical Statistics and IT Infrastructure, Hannover Medical School, Hannover, Lower Saxony, Germany
| | - Hans-Helmut König
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany
| | - Christian Brettschneider
- Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany
| | - Carolin van der Leeden
- Institute of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany
| | - Hendrik van den Bussche
- Institute of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany
| | - Angela Fuchs
- Institute of General Practice (ifam), Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, North Rhine-Westphalia, Germany
| | - Michael Pentzek
- Institute of General Practice (ifam), Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, North Rhine-Westphalia, Germany
| | - Siegfried Weyerer
- Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Baden-Württemberg, Germany
| | - Jochen Werle
- Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Baden-Württemberg, Germany
| | - Horst Bickel
- Department of Psychiatry, Technical University Munich, Munich, Bavaria, Germany
| | - Martin Scherer
- Institute of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany
| | - Wolfgang Maier
- Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, North Rhine-Westphalia, Germany
| | - Alfredo Ramirez
- Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, North Rhine-Westphalia, Germany
- German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany
- Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, North Rhine-Westphalia, Germany
- Department of Psychiatry & Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, TX, USA
- Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Steffi G Riedel-Heller
- Institute of Social Medicine, Occupational Health and Public Health, Medical Faculty, University of Leipzig, Leipzig, Saxony, Germany
| |
Collapse
|
2
|
Woo BK. Family history and its relationship with dementia stigma beliefs among Chinese Americans. Geriatr Gerontol Int 2015; 17:122-125. [PMID: 26694867 DOI: 10.1111/ggi.12686] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/15/2015] [Indexed: 01/24/2023]
Abstract
AIM It is known that Chinese Americans associate dementia with stigma and "loss of face." However, further research is required to provide a more complete picture of the extent and nature of stigma in Chinese Americans with family histories of dementia (FHD). The present study examined whether FHD are associated with quantitative measures of stigma in Chinese Americans. METHODS A total of 300 Chinese Americans in two health seminars answered a 15-item, true/false questionnaire to assess their beliefs toward dementia. Two groups were dichotomized and compared based on FHD. RESULTS Both groups subscribed to moderately stigmatizing views about dementia. Our findings showed that the group with FHD was more likely to disclose having relatives with dementia. However, this group was also more likely to perceive patients with dementia to be incapable of feeling other people's worries or concerns at once. CONCLUSIONS Strategies to decrease stigma toward dementia are required. Cultural interventions must also extend into the Chinese American general public to reduce stigma of dementia. Geriatr Gerontol Int 2017; 17: 122-125.
Collapse
Affiliation(s)
- Benjamin Kp Woo
- Olive View - UCLA Medical Center, University of California, Los Angeles, California, USA
| |
Collapse
|
3
|
Morrow LA, Snitz BE, Rodriquez EG, Huber KA, Saxton JA. High medical co-morbidity and family history of dementia is associated with lower cognitive function in older patients. Fam Pract 2009; 26:339-43. [PMID: 19584123 PMCID: PMC2743736 DOI: 10.1093/fampra/cmp047] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Risk factors for cognitive decline in ageing are multifactorial, including medical co-morbidities and familial genetic risk. OBJECTIVES To assess the effect of medical co-morbidity and family history of dementia on cognitive performance in older outpatients of family practitioners. METHODS Analysis of 535 outpatients from 11 practices aged 65 and older, without a diagnosis of dementia. Information on medical co-morbidities, family history of dementia and cognitive test data were obtained. RESULTS Patients were classified into high or low medical co-morbidities (<7 versus >8) and positive or negative family history of dementia. After controlling for age, education, gender and depression, global cognitive test scores, as well as memory, executive function, spatial ability and attention were significantly lower for persons having a high number of medical co-morbidities. Cognitive test scores were not significantly different for persons with or without a family history of dementia. A significant interaction between medical co-morbidities and family history of dementia was observed for the global cognitive score, executive function and spatial ability. Those persons with a high number of medical co-morbidities and positive family history of dementia had the lowest performance. Separate regression analysis assessing individual disease risk factors (e.g. hypertension and diabetes) did not find any relationship between specific medical variables and cognitive test scores for any of the subgroups. CONCLUSIONS A high number of medical co-morbidities in addition to a reported family history of dementia are particularly detrimental to cognitive performance in elderly non-demented family practice patients.
Collapse
Affiliation(s)
- Lisa A Morrow
- Department of Psychiatry, University of Pittsburgh, PA, USA.
| | | | | | | | | |
Collapse
|
4
|
Cortes F, Gillette-Guyonnet S, Nourhashemi F, Christelle C, Vellas B. Family history of dementia does not influence the progression of Alzheimer's disease at two years: results from the REAL.FR Study. Am J Alzheimers Dis Other Demen 2006; 21:131-6. [PMID: 16634470 PMCID: PMC10833240 DOI: 10.1177/153331750602100214] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The purpose of this study was to determine whether a family history of dementia in a first-degree relative influenced the progression of Alzheimer's disease (AD) after two years of follow-up. Patients were recruited in the REAL.FR (Réseau sur la Maladie d'Alzheimer Français) study and underwent behavioral, global, nutritional, and medical evaluation with assessment of cognitive function and independence every six months. At inclusion, 113 patients reported a family history of dementia, and 358 patients had no family history of dementia. There was no statistical difference for any factors between the two groups at baseline. After two years of follow-up, a similar percentage of patients were still followed in each group, and although most parameters showed significant deterioration, there was no difference between the two groups, indicating that a family history of dementia does not appear to influence the progression of AD.
Collapse
Affiliation(s)
- Frédéric Cortes
- Service de Médecine Interne et Gérontologie Clinique, Toulouse, France
| | | | | | | | | |
Collapse
|